Filing Details
- Accession Number:
- 0001104659-15-076190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-05 14:37:46
- Reporting Period:
- 2015-11-03
- Filing Date:
- 2015-11-05
- Accepted Time:
- 2015-11-05 14:37:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1552451 | Myokardia Inc | MYOK | Pharmaceutical Preparations (2834) | 455500552 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1121404 | Sanofi | 54 Rue La Boetie Paris I0 75008 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Par Value Per Share $ 0.0001 | Acquisiton | 2015-11-03 | 2,318,899 | $0.00 | 2,318,899 | No | 4 | C | Indirect | Via wholly owned subsidiary Aventis Inc. |
| Common Stock Par Value Per Share $ 0.0001 | Acquisiton | 2015-11-03 | 900,000 | $10.00 | 3,218,899 | No | 4 | P | Indirect | Via wholly owned subsidiary Aventis Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | Via wholly owned subsidiary Aventis Inc. |
| No | 4 | P | Indirect | Via wholly owned subsidiary Aventis Inc. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stocks | Series A-1 redeemable convertible preferred stock | Disposition | 2015-11-03 | 6,666,667 | $0.00 | 1,814,059 | $0.00 |
| Common Stocks | Series B redeemable convertible preferred stock | Disposition | 2015-11-03 | 1,855,288 | $0.00 | 504,840 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Conversion upon Initial Public Offering
Billionaire Hedge Funds
